NCT00788905
Unknown
Not Applicable
Uremic Toxin Removal, Blood Cell Kinetics, and Inflammatory Response in Patients Treated With the Allient System
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- End Stage Renal Disease
- Sponsor
- Renal Research Institute
- Enrollment
- 40
- Locations
- 3
- Primary Endpoint
- Clearance of specific waste products from blood determined through subject blood and dialysate samples
- Last Updated
- 13 years ago
Overview
Brief Summary
The purpose of the study to determine whether the level of inflammation may be decreased, the lifespan of red blood cells increased and the clearance of waste products in the blood improved through the use of the Allient System as compared to conventional hemodialysis.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Maintenance in-center hemodialysis
- •Age greater than or equal to 18 years
- •Has been on hemodialysis for at least 4 months
- •Uses a standard single-pass dialysis machine with a high-flux dialyzer
Exclusion Criteria
- •Hospitalization during the 8 weeks preceding enrollment
- •Infection requiring antibiotic treatment during the 8 weeks preceding enrollment
- •Central venous cather as dialysis access
- •Uncontrollable blood coagulation anomalies
- •Dialysis regimen other than 3 times weekly
- •In ability to understand the English language and give informed consent for participation in the study
Outcomes
Primary Outcomes
Clearance of specific waste products from blood determined through subject blood and dialysate samples
Time Frame: 3 weeks
Secondary Outcomes
- Inflammation as determined by levels of specific inflammatory markers(3 weeks)
- Red blood cell lifespan determined through a measurement of CO in the subject's breath(3 weeks)
Study Sites (3)
Loading locations...
Similar Trials
Completed
Not Applicable
Hemofilter Life Span, ECLS And/or CRRTKidney DiseasesAcute Injury of KidneyRenal FailureRenal InsufficiencyNeonatal Renal Disorder (Disorder)NCT04193865Medical University of South Carolina10
Completed
Phase 1
Role of Neutrophils and Electro-bioluminescence in the RehabilitationNonsmall-cell Lung CancerNCT06209229MIPO Clinic34
Recruiting
Not Applicable
Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS)Acute Ischemic StrokeNCT06696703First Affiliated Hospital of Harbin Medical University200
Completed
Phase 1
A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the BodyRenal InsufficiencyHealthyNCT03302091Boehringer Ingelheim20
Completed
Phase 2
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaHyperuricemiaAlbuminuriaType 2 DiabetesNCT03118739AstraZeneca60